Clinical Trial Update: The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

View source ↗

Summary

A completed study compared the safety and effectiveness of warfarin and dabigatran in patients with atrial fibrillation within the DoD health care coverage; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2015-07-03